References
- Ganten D., Balz W., Hense H.-W., Schölkens B. A., Horstmann G., Lang R. E., Unger Th. Characterization and regulation of angiotensin (ANG) peptides in tissue of rabbits and primates. J. Hypertens. 1985; 3(Suppl.)S552–S553
- Schölkens B. A., Xiang J.-Z., Tilly H. Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations. Clin. Exp. Hypertens. 1984; 6(10 & 11)1807–1813
- Bardenheuer H., Schrader J. Relationship between myocardial oxygen consumption, coronary flow, and adenosine release in an improved isolated working heart preparation of guinea pigs. Circ. Res. 1983; 51: 263–271
- Cohen M. L., Kurz K. D. Angiotensin converting enzyme inhibition in tissue from spontaneously hypertensive rats after treatment with captopril or MK-421. J. Pharmacol. Exp. Ther. 1982; 220: 63–69
- Xiang J.-Z., Linz W., Becker H., Ganten D., Lang R., Schölkens B., Unger Th. Effect of converting enzyme inhibitors: Ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur. J. Pharmacol. 1985; 113: 215–223
- Van Gilst W. H., de Graeff P. A., Wesseling H., de Langen C. D.J. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors. A comparison of captopril, enalapril and Hoe 498. J. Cardiovasc. Pharmacol. 1986, in press
- Peach M. J. Molecular actions of Angiotensin. Biochem. Pharmacol. 1981; 30: 2745–2751
- Rösen P., Eckel J., Reinauer H. Influence of bradykinin on glucose uptake and metabolism studied in isolated cardiac myocytes and isolated perfused rat hearts. Hoppe-Seyler's Z. Physiol. Chem. 1983; 364: 1431–1438
- Heavey D. J., Barrow S. E., Hickling N. E., Ritter J. M. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985; 318: 186–187
- Lefer A. M., Peck R. C. Cardioprotective effects of enalapril in acute myocardial ischemia. Pharmacology 1984; 29: 61–69
- Discussion section. Angiotensin converting enzyme inhibitors: Mechanisms of action and clinical implications, Z. P. Horovitz. Urban & Schwarzenberg, Baltimore-Munich 1981; 181–195
- Velletri P., Bean B. L. The effects of captopril on rat aortic angiotensin-converting enzyme. J. Cardiovasc. Pharmacol. 1982; 4: 315–325
- Saye J. A., Singer H. A., Peach M. J. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension 1984; 6: 216–221
- Story D. F., Ziogas J. Role of the endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat. Br. J. Pharmacol. 1986; 87: 249–255
- Lückhoff A., Budek W., Holtz J., Busse R. Role of the endothelium in the vasomotor effects of angiotensin I in isolated arteries with or without inhibition by MK 422. J. Hypertens. 1985; 3(Suppl.)S279–S281